AUB
PTCT icon

Atlantic Union Bankshares’s PTC Therapeutics PTCT Stock Holding History

Atlantic Union Bankshares’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.12K Hold
75
– – ﹤0.01% 1414
2026
Q1 		$5.11K Sell
75
-75
-50% -$5.31K ﹤0.01% 1421
2025
Q4 		$11.4K Hold
150
– – ﹤0.01% 1232
2025
Q3 		$9.21K Sell
150
-150
-50% -$7.81K ﹤0.01% 1292
2025
Q2 		$14.7K Buy
+300
New +$14.2K ﹤0.01% 865

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Atlantic Union Bankshares's PTCT Position: Q2 2026 in Review

Atlantic Union Bankshares held its PTC Therapeutics (PTCT) position steady in Q2 2026 at 75 shares worth $6.12K. The position accounts for ﹤0.01% of the portfolio, ranked #1414.

Atlantic Union Bankshares first reported a position in PTCT in Q2 2025 and has held it in 5 quarters since. The position peaked at $14.7K in Q2 2025. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • Atlantic Union Bankshares held 75 shares of PTC Therapeutics worth $6.12K as of Q2 2026.
  • Atlantic Union Bankshares left its PTC Therapeutics share count unchanged in Q2 2026.
  • PTC Therapeutics made up ﹤0.01% of Atlantic Union Bankshares's portfolio in Q2 2026, its #1414 holding.
  • Atlantic Union Bankshares first reported a position in PTC Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • Atlantic Union Bankshares's PTC Therapeutics position peaked at $14.7K in Q2 2025.
  • 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Atlantic Union Bankshares's 13F filing for Q2 2026, filed 11 Aug 2026.